© Reuters. Virtual press conference on the COVID-19 vaccination programme in London
LONDON (Reuters) – More data is needed to access the effectiveness of vaccines against the so-called Brazil variant of COVID-19, an British health official said on Monday.
“The current vaccines have not yet been studied against this variant, and we will need to wait for further clinical and trial data to understand the vaccine effectiveness against this variant,” Susan Hopkins from Public Health England told a news conference.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.